lenalidomide has been researched along with Anasarca in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hountras, P; Lane, T | 1 |
Agathokleous, A; Georgiou, S; Kyriakou, G; Marnellos, P; Solomou, EE; Symeonidis, A | 1 |
Anzai, T; Fukushima, A; Iwano, H; Matsuno, Y; Nakano, I; Naya, M; Oyama-Manabe, N; Shimizu, A; Takahashi, Y | 1 |
Hobeika, L; Self, SE; Velez, JC | 1 |
Adami, F; Angelini, A; Cacciavillani, L; Cianci, A; De Lazzari, M; Fedrigo, M; Giorgi, B; Iliceto, S; Migliore, F; Perazzolo Marra, M; Tarantini, G; Thiene, G; Valente, M | 1 |
5 other study(ies) available for lenalidomide and Anasarca
Article | Year |
---|---|
A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Edema; Exercise Tolerance; Humans; Hypertension, Pulmonary; Lenalidomide; Male; Neoplasms, Plasma Cell; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Stem Cell Transplantation; Syncope; Tadalafil; Weight Loss | 2022 |
Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Dyspnea; Edema; Humans; Lenalidomide; Male; Muscle Weakness; Nails, Malformed; POEMS Syndrome; Skin; Smoldering Multiple Myeloma | 2019 |
POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
Topics: Cytokines; Dexamethasone; Drug Therapy, Combination; Edema; Female; Glucocorticoids; Humans; Lenalidomide; Magnetic Resonance Imaging; Middle Aged; POEMS Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Dysfunction, Left | 2019 |
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Topics: Acute Kidney Injury; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease Progression; Edema; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Renal; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Podocytes; Proteasome Inhibitors; Proteinuria; Pyrazines; Recurrence; Shock, Septic; Teniposide; Thalidomide; Thrombotic Microangiopathies | 2014 |
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern.
Topics: Bortezomib; Cardiomyopathies; Combined Modality Therapy; Defibrillators, Implantable; Dexamethasone; Edema; Emergencies; Heart; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin kappa-Chains; Kidney; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Nephrotic Syndrome; Paraproteinemias; Paraproteins; Recurrence; Syncope; Thalidomide; Torsades de Pointes; Transplantation, Autologous | 2016 |